Phase II study of petosemtamab and pembrolizumab for recurrent/metastatic HNSCC



Jerome Fayette, MD, Centre Lèon Bèrard, Lyon, France, shares insight into the results of a Phase II trial (NCT03526835), …

source

Leave a Reply

Your email address will not be published. Required fields are marked *

Amazon Affiliate Disclaimer

Amazon Affiliate Disclaimer

“As an Amazon Associate I earn from qualifying purchases.”

Learn more about the Amazon Affiliate Program